Skip to the page

Data / Form D filings / Onconetix, Inc.

Onconetix, Inc.: Form D filings

Onconetix, Inc., a biotechnology company in Cincinnati, OH, filed 3 Form D notices with the SEC between 2019 and 2025. The latest, on October 7, 2025, reports $13 million sold of a $13 million offering to 11 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
201 E. FIFTH STREET, SUITE 1900, Cincinnati, OH, 45202
Phone
(513) 620-4101
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
$1 - $1,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1782107

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 7, 2025New notice$12,977,670$12,977,67011Sep 22, 2025sec.gov
Oct 17, 2024New notice$2,000,000$2,000,0005Oct 2, 2024sec.gov
Jul 15, 2019New notice$6,979,980$6,979,9805Jul 1, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Simon TarshDirector
Karina FedaszExecutive Officer
Andrew OakleyDirector
Timothy RamdeenDirector
Thomas MeierDirector

Other biotechnology companies in Ohio that filed recently

Every Form D from the week of Oct 6, 2025 · All recent filings in Ohio · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Onconetix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.